While countries like Canada and China are expected to see generic semaglutide as early as 2026 due to different patent laws, the consensus among experts is that a true generic or biosimilar version of Ozempic will not be available in the United States until at least the early 2030s
Experts say people with healthy eating patterns have a lower risk of developing serious health problems, such as heart disease, obesity and type 2 diabetes
Combined with PlexusDx's transparent compounded pricing model, this information helps you and your provider weigh insurance-covered options against direct-pay alternatives with precision-guided decision-making
Endless possibilities for patient connection
To determine the specific acyl-carnitine species that were consistently elevated across the subgroup of patients with consistently abnormal acyl-carnitine panels, we examined the first two acyl-carnitine panels measured for each patient
Who should (and should not) take Semaglutide for weight loss